Mason researchers use DNA ‘origami’ to design novel vaccine platform

Four George Mason University researchers are part of a team developing a novel method to develop vaccines rapidly. Their new process takes advantage of DNA molecules’ self-assembly properties by folding them onto nanoparticles that mimic viruses, eliciting a robust protective immunity to COVID in mice.